SCM
TECH icon

Steadfast Capital Management’s Bio-Techne TECH Stock Holding History

Steadfast Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-160,000
Closed -$9.41M – 112
2025
Q4 		$9.41M Buy
+160,000
New +$9.72M 0.16% 71

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Steadfast Capital Management's TECH Position: Q1 2026 in Review

Steadfast Capital Management sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 160,000 shares — an estimated $9.41M sold.

Steadfast Capital Management first reported a position in TECH in Q4 2025 and held it in 1 quarter. The position peaked at $9.41M in Q4 2025. 585 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Steadfast Capital Management reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Steadfast Capital Management sold 160,000 Bio-Techne shares in Q1 2026, an estimated $9.41M.
  • Steadfast Capital Management first reported a position in Bio-Techne in Q4 2025 and held it in 1 quarter.
  • Steadfast Capital Management's Bio-Techne position peaked at $9.41M in Q4 2025.
  • 585 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Steadfast Capital Management's 13F filing for Q1 2026, filed 15 May 2026.